Aelan Cell Technologies news
SAN FRANCISCO, CA--(Marketwired - May 15, 2015) - Building on its recent formation of Mount Tam Biotechnologies, US Equity Holdings is actively expanding its interest in biotechnology and will shortly announce its next significant venture. US Equity Holdings establishes and supports high-growth organizations by creating or licensing valuable intellectual property, forming strong management teams and financing its initiatives to successful exits.
The US Equity Holdings team has been as
Stem cell transplants have been widely used as a treatment for cancer since the 1960s. In 2010, the FDA approved Provenge, a product designed to treat late-stage prostate cancer. Cell therapy products designed for treating cancer are expected to be a growth segment for the industry over the next five years.
According to the Al
San Francisco, CA - Aelan Cell Technologies today announced they have entered into an agreement with the Gladstone Institutes to further its studies on stem cell rejuvenation. This effort will be led by Meenakshi Gaur, Ph.D. of Aelan Cell Technologies and Kathryn Ivey, Ph.D. of the Gladstone Institutes.
Aelan Cell Technologies will be conducting a comparative study that will involve characterization of Aelan`s stem cell product against the "gold standard," induced pluripotent stem cel
Regenerative medicine is the use of tissue engineering and molecular biology to improve or replace biological function in human cells, tissues and organs. Research on adult stem cells has generated a great deal of excitement in this regard. Despite the challenges in understanding adult stem cell biology, the field of regenerative medicine is taking
SAN FRANCISCO, CA--(Marketwired - Jun 2, 2015) - US Equity Holdings announced today that it has secured funding to launch